Featured Firms
Presented by BigVoodoo
In a major shift of enforcement strategy, the DOJ has firmly taken control of the enforcement against pharmaceutical, biotechnology and medical-device manufacturers. The DOJ has signaled-via its most recent settlements over the course of two months- its enforcement will change the way companies promote and market therapeutic products in the future.
March 20, 2006 at 12:00 AM
1 minute read
The original version of this story was published on National Law Journal
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS